Agada Medical

About Agada Medical

Agada Medical, founded in 2016, is a HealthTech company operating from Kansas City, KS, specializing in decision and risk analysis for the healthcare market. The company was founded by Dr. Isador Lieberman, an orthopedic and spine surgeon who previously served as President of the Texas Back Institute and has held leadership roles at the Cleveland Clinic and the University of Toronto. With over 40 U.S. patents for spinal surgery instruments and implants, Dr. Lieberman's extensive background in clinical practice and medical device consultation for major companies like Medtronic and Johnson & Johnson informed Agada's mission. The leadership team also includes CEO Scott Gunnigle, who has 30 years of experience in emerging medical technologies.

The core of Agada Medical's business is to address the high failure rate in spine fusion surgeries, a problem that contributes to a multi-billion dollar cost to the healthcare system. The company is moving spinal surgery from a heuristic, experience-based practice to a science-based methodology. Agada has developed an Enterprise AI software platform called THE SPINE ORACLE™. This system assimilates anthropometric data, demographic information, and diagnostic imaging to create a "digital twin" of the patient. By using a deep neural learning network and biomechanical simulation, the software analyzes the forces acting on the patient's spine to predict surgical outcomes with greater accuracy. This allows clinicians to develop a comprehensive, data-driven surgical plan, potentially eliminating unnecessary surgeries and optimizing the results of those that are performed.

The company's offerings include the software platform and patient-specific, custom-programmed spinal implants developed using titanium additive manufacturing. Agada Medical operates on an enterprise-level B2B SaaS model, targeting a continuum of stakeholders. Its primary clients include spine surgery programs, surgeons, insurance payers, and hospital administrators. The business model is structured to generate revenue through various channels, including per-click fees, premium subscription models for insurers, and royalties. By providing predictive analytics, Agada aims to streamline the pre-authorization and pre-certification process for payers and help hospital administrators make better decisions regarding the site of service. The company has secured $4.18M in a Seed Round in June 2024, with Crocker Ventures listed as an investor.